Request Pricing

Global Infectious Disease Situation Update

Reporting Period: February 7–24, 2026

The AeroClenz Chief Medical Officer periodically reviews publicly available infectious disease surveillance reports from organizations such as the Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), and European Centre for Disease Prevention and Control (ECDC).

These summaries are intended to provide general awareness of global infectious disease activity relevant to international travel, healthcare systems, and high-traffic indoor environments.

This information is provided for situational awareness only and does not constitute medical advice.

Key Takeaways

For the period of February 7–24, 2026, several notable global infectious disease trends emerged:

  • Measles continues to present significant operational challenges due to its high transmissibility
  • Seasonal respiratory viruses remain the primary day-to-day burden across multiple regions
  • Mpox cases in Europe show ongoing transmission within defined networks
  • Cholera activity persists across multiple countries, particularly in resource-limited settings
  • Zoonotic and high-consequence pathogens remain under active global surveillance

Measles Activity: High Impact per Case

Measles remains one of the most operationally disruptive infectious diseases due to its ability to spread rapidly following a single exposure event.

As of February 19, 2026, the CDC reports 982 confirmed measles cases in the United States, with approximately 89 percent associated with outbreaks.

Recent reported cases include exposures at:

  • Ave Maria University (Florida)
  • St. Petersburg Catholic High School (Florida)

The Pan American Health Organization (PAHO) has also issued warnings regarding increasing measles activity across the Americas, emphasizing the importance of surveillance and vaccination coverage.

The potential for rapid spread, combined with the complexity of contact tracing and exposure management, continues to make measles a key public-health consideration in travel and congregate settings.

Seasonal Respiratory Viruses: Ongoing Operational Burden

Respiratory viruses remain the most consistent source of healthcare and operational strain globally.

According to WHO surveillance:

  • Influenza positivity remains just above 15 percent globally (week 6)
  • SARS-CoV-2 activity remains comparatively low

CDC FluView data (week ending February 14) indicates:

  • Continued influenza activity across the United States
  • Regional variation in dominant influenza strains (A vs B)

The ECDC reports:

  • Elevated respiratory illness consultations across much of the EU/EEA
  • Influenza activity declining but still elevated
  • RSV circulation ongoing
  • SARS-CoV-2 activity lower relative to influenza and RSV

These trends suggest continued pressure on healthcare systems and workforce availability across multiple regions.

Mpox in Europe: Clade I Signals and Surveillance

Mpox activity continues to be monitored in Europe, particularly with respect to clade I variants.

As of February 17, 2026, the ECDC reports:

  • 255 mpox cases across 10 EU/EEA countries since January 1, 2026
  • Evidence of ongoing transmission within defined social and sexual networks
  • Risk assessed as moderate for certain populations and low for the general population

Additionally, WHO reporting referenced by ECDC notes the identification of a recombinant strain involving clade Ib and clade IIb, highlighting the importance of genomic surveillance in tracking viral evolution.

Cholera: Persistent Multi-Country Activity

Cholera remains a significant public-health concern in multiple regions, particularly where water, sanitation, and hygiene (WASH) systems are under strain.

According to WHO Update #34:

  • 182 associated deaths
  • A 20 percent increase compared to the previous month
  • Cases reported across 19 countries

These trends underscore the continued importance of monitoring infectious disease risks in regions experiencing infrastructure challenges.

Zoonotic and High-Consequence Pathogens

Several zoonotic and high-consequence pathogens remain under active surveillance.

ECDC reports:

  • A confirmed human H5N1 case in Cambodia (February 14), associated with exposure to infected poultry
  • A human A(H10N3) case in China (Guangdong), with no evidence of human-to-human transmission

For Nipah virus:

WHO reports limited case counts in:

  • Bangladesh (linked to date palm sap exposure)
  • India (including healthcare-associated cases)

In both contexts, the risk of broader international spread remains low based on current assessments, though continued monitoring is emphasized given the potential severity of these pathogens.

Additional Diseases of Ongoing Interest

Other infectious disease trends noted during this period include:

  • Measles (global and Americas): ongoing outbreaks and immunity gaps
  • Influenza and RSV: continued circulation with regional variability
  • Mpox (Europe): sustained monitoring of clade I variants and recombinant strains
  • Cholera: ongoing multi-country activity
  • Zika virus: no acute surge during this period, but continued classification as a persistent arboviral risk

Summary

The global infectious disease landscape for mid-February 2026 is characterized by:

  • Continued measles resurgence with high impact per exposure event
  • Persistent respiratory virus activity as the primary operational burden
  • Regional mpox activity with evolving viral characteristics
  • Sustained cholera transmission in multiple countries
  • Ongoing monitoring of zoonotic and high-consequence pathogens

Public-health surveillance agencies continue to monitor these developments and publish updates as new information becomes available.

Sources referenced in this summary include the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), the European Centre for Disease Prevention and Control (ECDC), and peer-reviewed literature, including the Journal of Travel Medicine.

To learn more about AeroClenz, visit www.aeroclenz.com. Follow AeroClenz on social media for updates on research and technology developments.

LinkedIn: https://www.linkedin.com/company/aeroclenz

Facebook: https://www.facebook.com/AeroClenz

Instagram: https://www.instagram.com/aeroclenz_

Get Updates Automatically
Translate »
Scroll to Top

Michael Stroup

Chief Operations Officer

Michael is a results-driven leader with 20 years of experience improving operations to achieve greater organizational effectiveness, productivity, and performance across multiple industries. Most recently Michael served as Integration Engineering Manager at CooperSurgical, a leading fertility medical device manufacturer. Prior to CSI, he has a proven track record of driving operational and engineering excellence within medical device, food, electronics and automotive industries by leading day to day operations and providing effective strategic leadership/execution.  His expertise includes, but is not limited to, global production set up, process improvements, machinery design and compliance. Michaels holds a Bachelor of Science in Mechanical Engineering Technology and Industrial Automotive Technology from Indiana State University and a Master of Science in Industrial Technology from Indiana State University.

Matt Saberton

CEO, Founder, Co-Inventor

Matt has been passionate about aviation from a young age, earning his private pilot’s license in high school. After obtaining a degree in Aviation and Aerospace Science, he began his career as a flight instructor and then became an air ambulance pilot, where he recognized the importance of cabin cleanliness.

Rising through the ranks at one of the largest worldwide charter airlines, Matt became Captain and later Chief Pilot, gaining deep insights into maintaining safe environments in aviation. This experience led him to found Aeroclenz, Inc., where he now serves as CEO.

Under his leadership, Aeroclenz has transitioned from an aerospace-focused company to a leader in UV disinfection solutions, offering custom products for both aerospace and terrestrial indoor applications. While the company’s roots are in aviation, its technologies now ensure high standards of cleanliness across various industries.

Jameson Trettenero

Director of Marketing

Jameson is a seasoned marketing expert with experience driving strategic marketing initiatives across a diverse array of industries. In his role, Jameson leads the marketing efforts with a focus on innovative growth strategies, brand elevation, and data-driven decision-making that align with the company’s overarching business goals.

Before joining Aeroclenz, Jameson held key leadership positions at top-tier digital agencies. In his agency experience, he spearheaded multi-divisional teams across disciplines including SEO, Paid Media, Analytics, and Creative. His strategic oversight and client-centric approach significantly enhanced client retention and business growth, particularly across enterprise-level accounts.

Jameson’s expertise extends to managing complex client relationships, advising C-level executives, and navigating the intricacies of the marketing landscape. His ability to harmonize creativity with analytics has consistently driven measurable success for clients, from Fortune 500 companies to emerging brands.